View Older Stories View More Recent Stories
-
Ainos receives Taiwan approval for VELDONA clinical study
-
Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome
-
Water Tower Research Highlights Ainos' SmellTech Platform AI Nose as Foundational AI Innovation
-
Ainos launches AI scent-detection robots at seven Japan industrial sites
-
Ainos and ugo Launch World's First AI Nose-Enabled Service Robot Pilots in Seven Sites Across Japan's Industrial Sector
-
Ainos Regains Nasdaq Compliance, Sets 90-Day Roadmap to Scale AI Nose Platform in 2026
-
Water Tower Research Highlights Growing Momentum for Ainos' Scent-Tech Solutions and Industrial SmellTech Leadership with New High-Impact Partnerships
-
Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape
-
Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization
-
Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites
-
Ainos (AIMD) Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Reverse Share Split
-
Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation
-
Ainos (AIMD) and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia
-
Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia
-
Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25
-
Ainos (AIMD) Issues Mid-Year Update
-
Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy
-
Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter
-
Ainos (AIMD) vAI Nose Improves Accuracy in Hygiene Monitoring to 85% from 80%
-
Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%
-
Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner
-
Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy
-
Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors
-
Ainos Reports First Quarter 2025 Financial Results
-
Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing
-
Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly
-
Ainos (AIMD) and ugo Complete First Robotic Smell Integration in Japan
-
Ainos and ugo Complete First Robotic Smell Integration in Japan
-
Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025
-
Ainos (AIMD) and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing
-
Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing
-
Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here
-
Ainos (AIMD) and ugo to Develop a Robot With a Sense of Smell
-
Ainos and ugo to Develop the World's First Robot With a Sense of Smell
-
Ainos (AIMD) Receives Japan Patent Approval for VELDONA Redefines Antiviral Innovation
-
Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation
-
Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025
-
Ainos (AIMD) Granted Nasdaq Extension to Regain Compliance
-
Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule
-
Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots
-
CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA
-
Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA
-
Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement
-
Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing
-
Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug
-
Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments
-
Ainos Announces IRB Approval for Sjögren’s Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 20
-
Ainos (AIMD) Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities
-
Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities
-
Ainos Reports Third Quarter 2024 Financial Results
